Atlas Trials

Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer

Clinical trial NCT07368543 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07368543
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2026-01-16
Primary completion
2027-06-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.